Page 123 - GPD-3-2

Gene & Protein in Disease The effect of myostatin on muscle-related miRNAs

doi: 10.1073/pnas.0710558105 doi: 10.1038/mt.2014.90
17. Callis TE, Chen JF, Wang DZ. MicroRNAs in skeletal 25. Pearsall RS, Davies MV, Cannell M, et al. Follistatin-based
and cardiac muscle development. DNA Cell Biol. ligand trap ACE-083 induces localized hypertrophy of
2007;26(4):219-225. skeletal muscle with functional improvement in models of
doi: 10.1089/dna.2006.0556 neuromuscular disease. Sci Rep. 2019;9(1):11392.
18. van Rooij E, Liu N, Olson EN. MicroRNAs flex their muscles. doi: 10.1038/s41598-019-47818-w
Trends Genet. 2008;24(4):159-166. 26. LeBrasseur NK, Schelhorn TM, Bernardo BL, Cosgrove PG,
doi: 10.1016/j.tig.2008.01.007 Loria PM, Brown TA. Myostatin inhibition enhances the
effects of exercise on performance and metabolic outcomes in
19. Rachagani S, Cheng Y, Reecy JM. Myostatin genotype aged mice. J Gerontol A Biol Sci Med Sci. 2009;64(9):940-948.
regulates muscle-specific miRNA expression in mouse
pectoralis muscle. BMC Res Notes. 2010;3:297. doi: 10.1093/gerona/glp068
doi: 10.1186/1756-0500-3-297 27. Braga M, Pervin S, Norris K, Bhasin S, Singh R. Inhibition
of in vitro and in vivo brown fat differentiation program by
20. Wada S, Kato Y, Okutsu M, et al. Translational suppression myostatin. Obesity (Silver Spring). 2013;21(6):1180-1188.
of atrophic regulators by microRNA-23a integrates
resistance to skeletal muscle atrophy. J Biol Chem. doi: 10.1002/oby.20117
2011;286(44):38456-38465. 28. Wang P, Liu Z, Zhang X, et al. CRISPR/Cas9-mediated
doi: 10.1074/jbc.M111.271270 gene knockout reveals a guardian role of NF-κB/RelA
in maintaining the homeostasis of human vascular cells.
21. Weng S, Gao F, Wang J, et al. Improvement of muscular Protein Cell. 2018;9(11):945-965.
atrophy by AAV-SaCas9-mediated myostatin gene editing
in aged mice. Cancer Gene Ther. 2020;27(12):960-975. doi: 10.1007/s13238-018-0560-5
doi: 10.1038/s41417-020-0178-722 29. Pascucci FA, Ladelfa MF, Toledo MF, Escalada M,
Suberbordes M, Monte M. MageC2 protein is upregulated
22. Li S, Sun Z, Chen T, et al. The role of miR-431-5p in by oncogenic activation of MAPK pathway and causes
regulating pulmonary surfactant expression in vitro. Cell impairment of the p53 transactivation function. Biochim
Mol Biol Lett. 2019;24:25.
Biophys Acta Mol Cell Res. 2021;1868(3):118918.
doi: 10.1186/s11658-019-0150-4
doi: 10.1016/j.bbamcr.2020.118918
23. Giannesini B, Vilmen C, Amthor H, Bernard M, Bendahan D. 30. Hitachi K, Nakatani M, Tsuchida K. Myostatin signaling
Lack of myostatin impairs mechanical performance and regulates Akt activity via the regulation of miR-486
ATP cost of contraction in exercising mouse gastrocnemius expression. Int J Biochem Cell Biol. 2014;47:93-103.
muscle in vivo. Am J Physiol Endocrinol Metab.
2013;305(1):E33-E40. doi: 10.1016/j.biocel.2013.12.003
doi: 10.1152/ajpendo.00651.201224 31. Wu R, Li H, Li T, Zhang Y, Zhu D. Myostatin regulates
miR-431 expression via the Ras-Mek-Erk signaling pathway.
24. Relizani K, Mouisel E, Giannesini B, et al. Blockade of
ActRIIB signaling triggers muscle fatigability and metabolic Biochem Biophys Res Commun. 2015;461(2):224-229.
myopathy. Mol Ther. 2014;22(8):1423-1433. doi: 10.1016/j.bbrc.2015.03.150

Volume 3 Issue 2 (2024) 10 doi: 10.36922/gpd.2991